Deregulated Expression of Superoxide Dismutase-2 Correlates with Different Stages of Cervical Neoplasia

Objective: Superoxide dismutase-2 (SOD2) is considered one of the most important antioxidant enzymes that regulate cellular redox state in normal and tumorigenic cells. Overexpression of this enzyme may be involved in carcinogenesis, particularly in lung, gastric, colorectal and breast cancer. Methods: In the present study, we have evaluated SOD2 protein levels by immunohistochemistry (IHC) in 331 cervical histological samples including 31 low-grade cervical intraepithelial neoplasia (LSIL), 51 high-grade cervical intraepithelial neoplasia (HSIL), 197 squamous cervical carcinomas (SCC) and 52 cervical adenocarcinomas (ADENO). Results: We observed that SOD2 staining increases with cervical disease severity. Intense SOD2 staining was found in 13% of LSIL, 25.5% of HSIL and 40% of SCC. Moreover, 65.4% of ADENO exhibited intense SOD2 staining. Conclusions: Differences in the expression of SOD2 could potentially be used as a biomarker for the characterization of different stages of cervical disease.

[1]  A. Longatto-Filho,et al.  Analysis of human kallikrein 7 expression as a potential biomarker in cervical neoplasia , 2010, International journal of cancer.

[2]  D. S. St. Clair,et al.  Manganese superoxide dismutase: beyond life and death , 2010, Amino Acids.

[3]  A. Kolokythas,et al.  Deregulation of manganese superoxide dismutase (SOD2) expression and lymph node metastasis in tongue squamous cell carcinoma , 2010, BMC Cancer.

[4]  D. S. St. Clair,et al.  Regulation of superoxide dismutase genes: implications in disease. , 2009, Free radical biology & medicine.

[5]  Gustavo H. Esteves,et al.  Characterization of global transcription profile of normal and HPV-immortalized keratinocytes and their response to TNF treatment , 2008, BMC Medical Genomics.

[6]  M. Moreira,et al.  How accurate is cytological diagnosis of cervical glandular lesions? , 2008, Diagnostic cytopathology.

[7]  J. Cuzick,et al.  Cervical cancer screening following prophylactic human papillomavirus vaccination. , 2008, Vaccine.

[8]  J. Salomon,et al.  Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination. , 2008, Journal of the National Cancer Institute.

[9]  A. Longatto-Filho,et al.  Molecular techniques in cytopathology practice , 2007, Journal of Clinical Pathology.

[10]  T. Hwang,et al.  Differential expression of manganese superoxide dismutase, copper/zinc superoxide dismutase, and catalase in gastric adenocarcinoma and normal gastric mucosa. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[11]  S. Gayther,et al.  Molecular profiling of cervical cancer progression , 2007, British Journal of Cancer.

[12]  T. O’Halloran,et al.  Activation of superoxide dismutases: putting the metal to the pedal. , 2006, Biochimica et biophysica acta.

[13]  K. Baek,et al.  Differential expression of manganese superoxide dismutase sequence variants in near isogenic lines of wheat during cold acclimation , 2006, Plant Cell Reports.

[14]  C. Giulivi,et al.  Superoxide dismutases and their impact upon human health. , 2005, Molecular aspects of medicine.

[15]  D. S. St. Clair,et al.  Modulation of skin tumorigenesis by SOD. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[16]  Y. Soini,et al.  Differential expression of superoxide dismutases in lung cancer. , 2004, American journal of clinical pathology.

[17]  J. Crapo,et al.  Superoxide dismutases in malignant cells and human tumors. , 2004, Free radical biology & medicine.

[18]  L. Oberley,et al.  Inhibition of Cell Growth by Overexpression of Manganese Superoxide Dismutase (MnSOD) in Human Pancreatic Carcinoma , 2004, Free radical research.

[19]  T. Rohan,et al.  Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. , 2003, Journal of the National Cancer Institute.

[20]  J. Crapo,et al.  Superoxide dismutases in the lung and human lung diseases. , 2003, American journal of respiratory and critical care medicine.

[21]  H. Haapasalo,et al.  Expression of Antioxidant Enzymes in Astrocytic Brain Tumors , 2003, Brain pathology.

[22]  L. Oberley,et al.  The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma. , 2003, Cancer research.

[23]  W. McCluggage,et al.  Endocervical glandular lesions: controversial aspects and ancillary techniques , 2003, Journal of clinical pathology.

[24]  Eileen M. Burd,et al.  Human Papillomavirus and Cervical Cancer , 1988, The Lancet.

[25]  S. Erzurum,et al.  Differential expression of manganese superoxide dismutase and catalase in lung cancer. , 2001, Cancer research.

[26]  Y. Soini,et al.  MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non‐neoplastic breast epithelial cells , 2001, The Journal of pathology.

[27]  C. Bosman,et al.  Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  D. Bostwick,et al.  Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer , 2000, Cancer.

[29]  K. Sugimachi,et al.  Overexpression of manganese superoxide dismutase mRNA may correlate with aggressiveness in gastric and colorectal adenocarcinomas. , 2000, International journal of oncology.

[30]  R. Zaino.  Glandular Lesions of the Uterine Cervix , 2000, Modern Pathology.

[31]  J. Margenthaler,et al.  MnSOD expression is increased in metastatic gastric cancer. , 2000, The Journal of surgical research.

[32]  C. V. D. van de Velde,et al.  Superoxide dismutases in the human colorectal cancer sequence , 1999, Journal of Cancer Research and Clinical Oncology.

[33]  D. Kuroda,et al.  Expression of manganese superoxide dismutase in esophageal and gastric cancers , 1998, Journal of Gastroenterology.

[34]  L. Oberley,et al.  Expression of antioxidant enzymes in human prostatic adenocarcinoma , 1997, The Prostate.

[35]  L. Oberley,et al.  Transfection and expression of MnSOD cDNA decreases tumor malignancy of human oral squamous carcinoma SCC-25 cells. , 1997, Human gene therapy.

[36]  D. S. St. Clair,et al.  Inhibition of cell growth and sensitization to oxidative damage by overexpression of manganese superoxide dismutase in rat glioma cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[37]  D. S. St. Clair,et al.  Manganese-containing superoxide dismutase overexpression causes phenotypic reversion in SV40-transformed human lung fibroblasts. , 1996, Cancer research.

[38]  P. Meltzer,et al.  Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[39]  N. Bianchi,et al.  Superoxide dismutase activity and superoxide dismutase-1 gene methylation in normal and tumoral human breast tissues. , 1992, Cancer genetics and cytogenetics.